KRAS mutations and relation to prognosis in patients operated for localized pancreatic cancer and other periampullary cancers.


e15618 Background: Prognostic biomarkers in patients with pancreatic cancer might direct patients to optimal treatment. We studied the prognostic value of KRAS mutations in patients operated for pancreatic and other periampullary cancers. METHODS Retrospective study of 328 patients who were operated with a Whipples procedure at a single HBP-center during… (More)


  • Presentations referencing similar topics